The results of the present study demonstrate that ATO reduces the infiltration of macrophages into the TME and impairs IL-1β secretion by macrophages, thereby inhibiting ICAM1 activation and leading to the sensitization of HNSCC to DTX. Here, ICAM1 is linked to head and neck squamous cell carcinoma.